Literature DB >> 16953638

Comparison of the specificity of interaction of cellular and viral zinc-binding domains with 2-mercaptobenzamide thioesters.

Lisa M Miller Jenkins1, Stewart R Durell, Andrew T Maynard, Stephen J Stahl, John K Inman, Ettore Appella, Pascale Legault, James G Omichinski.   

Abstract

The interactions of two 2-mercaptobenzamide thioester compounds with six diverse zinc-binding domains (ZBDs) have been analyzed by UV/visible spectroscopy, NMR spectroscopy, and nucleic acid binding assays. These thioester compounds serve as useful tools for probing the intrinsic chemical stability of ZBDs that exist within a variety of cellular and viral proteins. In our studies, the classical (Cys(2)His(2)) zinc finger ZBDs, the interleaved RING like ZBDs of protein kinase C delta (Cys(2)HisCys and HisCys(3)), and the carboxyl-terminal (Cys(2)HisCys) ZBD of Mouse Mammary Tumor Virus nucleocapsid protein (MMTV NCp10) were resistant to reaction with the thioester compounds. In contrast, the thioester compounds were able to efficiently eject zinc from the amino-terminal (Cys(2)HisCys) ZBD of MMTV NCp10, a Cys(2)HisCys ZBD from Friend of GATA-1 (FOG-1), and from both Cys(4) ZBDs of GATA-1. In all cases, zinc ejection led to a loss of protein structure. Interestingly, GATA-1 was resistant to reaction with the thioester compounds when bound to its target DNA sequence. The electronic and steric screening was calculated for select ZBDs to further explore their reactivity. Based on these results, it appears that both first and second zinc-coordination shell interactions within ZBDs, as well as nucleic acid binding, play important roles in determining the chemical stability and reactivity of ZBDs. These studies not only provide information regarding the relative reactivity of cysteine residues within structural ZBDs but also are crucial for the design of future therapeutic agents that selectively target ZBDs, such as those that occur in the HIV-1 nucleocapsid protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953638     DOI: 10.1021/ja063329e

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  9 in total

Review 1.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

Review 2.  HIV type 1 Gag as a target for antiviral therapy.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-21       Impact factor: 2.205

3.  Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer.

Authors:  Lisa M Miller Jenkins; David E Ott; Ryo Hayashi; Lori V Coren; Deyun Wang; Qun Xu; Marco L Schito; John K Inman; Daniel H Appella; Ettore Appella
Journal:  Nat Chem Biol       Date:  2010-10-17       Impact factor: 15.040

4.  Requirement of the zinc-binding domain of ClpX for Spx proteolysis in Bacillus subtilis and effects of disulfide stress on ClpXP activity.

Authors:  Ying Zhang; Peter Zuber
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

Review 5.  Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.

Authors:  Mattia Mori; Lesia Kovalenko; Sébastien Lyonnais; Danny Antaki; Bruce E Torbett; Maurizio Botta; Gilles Mirambeau; Yves Mély
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

6.  6th international symposium on retroviral nucleocapsid.

Authors:  Ben Berkhout; Robert Gorelick; Michael F Summers; Yves Mély; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2008-02-25       Impact factor: 4.602

7.  Targeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activity.

Authors:  Claudia S Sepúlveda; Cybele C García; Jesica M Levingston Macleod; Nora López; Elsa B Damonte
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

8.  Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein.

Authors:  Min-Jung Kim; Seon Hee Kim; Jung Ae Park; Kyung Lee Yu; Soo In Jang; Byung Soo Kim; Eun Soo Lee; Ji Chang You
Journal:  Retrovirology       Date:  2015-11-06       Impact factor: 4.602

9.  Investigation of the Low-Populated Excited States of the HIV-1 Nucleocapsid Domain.

Authors:  Assia Mouhand; Loussiné Zargarian; Anissa Belfetmi; Marjorie Catala; Marco Pasi; Ewen Lescop; Carine Tisné; Olivier Mauffret
Journal:  Viruses       Date:  2022-03-18       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.